Genomic Vision Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2022
For the full year Total revenue from activity was 1,480,000 against 1,413,000 reported a year ago.
1st Jan change | Capi. | |
---|---|---|
+17.25% | 44.44B | |
-9.86% | 37.99B | |
+37.12% | 37.75B | |
+26.81% | 30.78B | |
-8.64% | 27.38B | |
+12.30% | 26.17B | |
+43.86% | 14.15B | |
+33.20% | 12.59B | |
-7.37% | 11.28B |